发明名称 Formulations comprising methylthioninium chloride
摘要 Solid dosage forms of methylthioninium chloride (MTC) further comprise at least one diluent suitable for direct compression. The MTC exists in a substantially pure and stable polymorphic form. The solid dosage forms may preferably be prepared by direct compression methods.
申请公布号 US9192611(B2) 申请公布日期 2015.11.24
申请号 US201113989953 申请日期 2011.11.30
申请人 WisTa Laboratories Ltd. 发明人 Khan Karrar Ahmad
分类号 A61K31/5415;A61K9/16;A61K9/20;A61K9/48;C07D279/18 主分类号 A61K31/5415
代理机构 Foley & Lardner LLP 代理人 Foley & Lardner LLP
主权项 1. A tablet pharmaceutical composition in solid dosage form comprising: (a) substantially pure and stable polymorph Form A methylthioninium chloride (“MTC”), (b) at least one diluent suitable for direct compression selected from microcrystalline cellulose or a sugar, (c) optionally further comprising a coating and (d) optionally one or more other excipients, wherein the amount of MTC in the composition is 10-75% w/w of the weight of composition without the coating, and wherein the composition is obtained by a process comprising dry compression of an intimate powder mixture of the MTC in a substantially pure polymorphic form with the at least one diluent suitable for direct compression.
地址 Singapore SG